By: IPP Bureau
Last updated : September 23, 2026 4:37 pm
Lamba will be overseeing strategic domains across Intas Pharmaceuticals and its global subsidiary, Accord Healthcare
Intas Pharmaceuticals Limited has appointed Taranpreet Singh Lamba as the new Executive Vice President – Global Intellectual Property Rights (IPR) & Portfolio for India and Emerging Markets.
In his new position, Lamba will be overseeing strategic domains across Intas Pharmaceuticals and its global subsidiary, Accord Healthcare. His core responsibilities include Overseeing corporate intellectual property strategies, generic patent prosecutions, and high-stakes litigation. He will also be managing global product portfolios, development roadmaps, and business growth mechanisms tailored specifically for India and high-growth emerging markets.
Lamba is a seasoned pharmaceutical industry veteran with exhaustive expertise in corporate portfolio strategy and patent laws. Prior to joining Intas Pharmaceuticals, Lamba worked with Glenmark Pharmaceuticals, Sun Pharmaceutical Industries and Torrent Pharmaceuticals.